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Abstract  10 
Background 11 
The emergence of antimicrobial resistance (AMR) in zoonotic foodborne pathogens 12 
(Salmonella, Campylobacter) and indicator microorganisms (E. coli, enterococci) is a major 13 
public health risk. Zoonotic bacteria, resistant to antimicrobials, are of special concern 14 
because they might compromise the effective treatment of infections in humans.  15 
Scope and approach 16 
In this review, the AMR monitoring and surveillance programmes in five selected countries 17 
within European Union (EU) and European Economic Area (EEA) are described. The 18 
sampling schemes, susceptibility testing for AMR identification, clinical breakpoints (clinical 19 
resistance) and epidemiological cut-off values (microbiological resistance) were considered 20 
to reflect on the most important variations between and within food-producing animal 21 
species, between countries, and to identify the most effective approach to tackle and manage 22 
the antimicrobial resistance in the food chain.  23 
Key findings and conclusions 24 
The science-based monitoring of AMR should encompass the whole food chain, supported 25 
with public health surveillance and should be conducted in accordance with `Zoonoses 26 
Directive` (99/2003/EC). Such approach encompasses the integrated AMR monitoring in 27 
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food animals, food and humans in the whole food (meat) chain continuum, e.g. pre-harvest 28 
(on-farm), harvest (in abattoir) and post-harvest (at retail). The information on AMR in 29 
critically important antimicrobials (CIA) for human medicine should be of particular 30 
importance. 31 
Keywords: antimicrobial resistance, foodborne pathogens, monitoring, surveillance, 32 
public health.  33 
 34 
1. Introduction 35 
In the last decade the antimicrobial resistance (AMR) associated with zoonotic foodborne 36 
pathogens of bacterial origin is recognized as a major public health concern. Zoonotic 37 
foodborne bacteria are infectious agents which may be transferred from animals to humans 38 
via food ingestion (WHO, 2015). Zoonotic agents are believed to be responsible for up to 39 
75% of infectious diseases in humans (Heymann, 2004; Behravesh et al., 2012). Therefore, 40 
food-producing animals (cattle, sheep, pigs and poultry) are of particular importance for 41 
emergence and transfer of AMR through the food consumption taking into consideration the 42 
intensive, on-farm production practice frequently associated with misuse/overuse of 43 
antimicrobials (Bischt et al., 2009). 44 
It is well known that from 1940’s, introduction of antibiotics to treat infectious diseases in 45 
humans and animals revolutionized medicine. When it comes to food animals, antibiotics are 46 
used not only to treat them against infectious diseases but also to prevent disease 47 
development (metaphylaxis) and to promote their growth. However, the overuse and misuse 48 
of antibiotics in food animals can lead to selective pressure on microorganisms and may 49 
result in development and spread of antibiotic resistance (Cogliani et al., 2011). The first 50 
integrated analysis on antimicrobial consumption in veterinary and human medicine at the 51 
level of European Union (EU) and European Economic Area (EEA) was conducted in 2015 52 
(ECDC/EFSA/EMA, 2015); the report aimed to provide better insight to the occurrence of 53 
antimicrobial resistance in bacteria originated from humans and food animals. The excessive 54 
veterinary use of antimicrobials applicable mainly for food-producing animal species, 55 
including horses, in 26 European Union and European Economic Area countries was 56 
estimated to be in total 7,982 tonnes per year, with the highest level of antimicrobial 57 
consumption in pigs, cattle and poultry; additionally, the overall quantity of antibiotic 58 
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consumption in humans was in total 3,399.8 tonnes per year. Evidently, a significant amount 59 
of antimicrobial agents per year are consumed in both, food animals and humans in EU and 60 
EEA countries. Such practice may have important consequences for public health, as it may 61 
promote development of antibiotic-resistant bacteria and transfer of resistance genes to 62 
humans (WHO, 2011a). Nowadays, this causes serious treatment failures or necessitate the 63 
use of second-line antimicrobials for therapy, more severe and longer-lasting disease, 64 
increased hospitalization rates, including increased mortality, sequelae, and ultimately, higher 65 
costs to society (WHO, 2011a). Having in mind the complexity of the international food trade 66 
characterized with a longer food supply chain, as well as possibility for transfer of foodborne 67 
pathogens from one country/continent to another within a short period of time, antibiotic 68 
resistance became a growing international health issue; it deserves immediate attention by 69 
health, veterinary, food and environmental authorities on the global scale.  70 
Antimicrobial resistance associated with major zoonotic foodborne pathogens (Salmonella, 71 
Campylobacter) occurring in food animals can spread to people via food/water consumption 72 
and direct animal-human contact. In addition, commensal bacteria (e.g. E. coli, enterococci), 73 
can also form a reservoir of resistance genes in environment, farm and food animals (Barton, 74 
2000). This may facilitate transfer between bacterial species, including the transfer to 75 
pathogens capable of causing disease in both humans and animals which may be difficult to 76 
cure (EFSA, 2008).  77 
In the European Union (EU) and European Economic Area (EEA), AMR became a very 78 
serious public health challenge. The magnitude of the problem is highlighted by the fact that 79 
more than 25 000 people die each year from infections caused by antibiotic resistant bacteria 80 
(ECDC/EMEA, 2009). The resistance rate to antibiotics is high among both, Gram-positive 81 
and Gram-negative bacteria that cause serious infections in humans and reaches 25% or more 82 
in several EU Member States (ECDC/EMEA, 2009). The ineffective antibiotic treatments 83 
result in extra healthcare costs and productivity losses of at least EUR 1.5 billion each year. 84 
In addition, there is a gap between the burden of infections due to multidrug-resistant bacteria 85 
and the development of new, effective antibiotics to tackle the problem. There are numerous 86 
studies to highlight the problem related to AMR and to identify the sources and causes for 87 
development of this phenomenon, but it is still uncertain how much it can be contributed to 88 
the food chain, in particular meat chain.  89 
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The aim of this paper was to review the AMR monitoring and surveillance schemes in five 90 
selected EU and EEA countries with focus on the contribution of the meat chain to 91 
emergence, development and spread of antimicrobial resistance to humans. An overview of 92 
the sampling schemes, susceptibility testing for AMR profile identification, clinical 93 
breakpoints (clinical resistance) and epidemiological cut-off values (microbiological 94 
resistance) were considered, including the most important differences between and within 95 
food-producing animal species, between countries, and identification of the most effective 96 
risk mitigation strategies to tackle the antimicrobial resistance in the meat chain.  97 
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Table 1. Summary of selected studies linking AMR to the meat chain 98 
Authors Type of article Research focus Module in the meat chain 
1 2 3 4 5 
Andersen et al. (2006) Journal Article Antimicrobial resistance among Campylobacter jejuni 
from raw poultry meat in retail in Denmark 
   X  
DANMAP (2014) Scientific Report Use of antimicrobial agents and occurrence of 
antimicrobial resistance in bacteria from food 
animals, food and humans in Denmark 
X X X X X 
ECDC (2014) Summary Report The European Union Summary report on 
antimicrobial resistance in zoonotic and indicator 
bacteria from humans, animals and food in 2014 
X X X  X 
EFSA (2014) Scientific Report Technical specifications on randomised sampling for 
harmonised monitoring  of antimicrobial resistance in 
zoonotic and commensal bacteria 
X X X X  
Gallay et al. (2007) Journal Article Campylobacter antimicrobial resistance among 
humans, broiler chickens and pigs. France 
 X   X 
Leegard et al. (2000) Journal Article Emerging antimitotic resistance in Salmonella     X 
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typhimurium in Norway 
Lindmark et al. (2004) Journal Article Genetic characterisation and antimicrobial resistance 
of Campylobacter jejuni isolated from meats, water 
and humans in Sweden 
   X X 
MARAN (2013) Scientific Report Monitoring of antimicrobial resistance and antibiotic 
usage in animals in the Netherlands in 2012 
X X X X  
NORM-VET (2013) Scientific Report Usage of antimicrobial agents and occurrence of 
antimicrobial resistance in Norway 
X X X  X 
RESAPATH (2012) Scientific Report French Surveillance network for antimicrobial 
resistance in pathogenic bacteria from animal origin 
X     
SVARM (2014) Scientific Report Consumption of antibiotics and occurrence of 
antibiotic resistance in Sweden 
X X X  X 
Modules: 1 = Farm; 2 = Abattoir; 3 = Meat Processing; 4 = Retail; 5 – Consumers99 
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A literature review was performed by analysing published scientific papers and the major 100 
sources of information originated from the scholarly databases such as Web of Science, 101 
EBSCO and ScienceDirect. The official web-sites of selected national monitoring and 102 
surveillance schemes were also analysed, including the European Antimicrobial Resistance 103 
Surveillance Network (EARS-Net) and Antimicrobial Consumption Interactive database 104 
(ESAC-Net). This review identified relevant articles (research and review papers, technical 105 
reports by international organizations) and databases, published in domains of zoonotic 106 
foodborne pathogens and related antimicrobial resistance, including the public health impact. 107 
The selection criteria chosen to identify the relevant articles within the scope of this review 108 
and the objectives of this paper were as follow: 1) focus on the specific AMR monitoring and 109 
surveillance programmes with well-established databases regarding meat chain-associated 110 
antimicrobial resistance; 2) focus on the potential for improvement of harmonization of 111 
national monitoring and surveillance systems and future research. However, some 112 
geographical restrictions were taken, by including selected countries with intensive 113 
experience and well-established AMR monitoring and surveillance programmes.  Therefore, 114 
monitoring and surveillance programmes on antimicrobial usage and antimicrobial resistance 115 
of the major zoonotic foodborne pathogens with public health importance (Salmonella, 116 
Campylobacter) and indicator bacteria (E. coli, Enterococcus spp.) were reviewed in four EU 117 
Member States (MSs) (Denmark, Sweden, France and Netherlands) and one EEA country 118 
(Norway) (Table 2).119 
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Table 2. Monitoring and surveillance programmes of four selected EU member states and 1 EEA country  120 
Programme Type of surveillance Country Source 
animals food humans 
Danish Integrated 
Antimicrobial Resistance 
Monitoring and Research 
Programme (DANMAP) 
x x x Denmark  
(EU) 
www.danmap.org  
French surveillance 
network for antimicrobial 
resistance in pathogenic 
bacteria of animal origin 
(RESAPATH) 
x  x France  
(EU) 
www.resapth.org   
https://www.anses.fr/en/thematique/veterina
ry-medicine-anmv   
Monitoring of 
Antimicrobial Resistance 
and Antibiotic Usage in the 
Netherlands (MARAN) 
x x x The 
Netherlands 
(EU) 
http://www.wageningenur.nl/en/Expertise-
Services/Research-Institutes/Central-
Veterinary-Institute.htm  
Swedish Veterinary 
Antimicrobial Resistance 
Monitoring (SVARM) 
x  x Sweden 
(EU) 
http://www.sva.se/en/antibiotika/svarm-
reports  
Norwegian Surveillance 
System for Antimicrobial 
Drug Resistance 
(NORM/NORM-VET) 
x x x Norway 
(EEA) 
www.vetinst.no/eng/Research/Publications/
Norm-Norm-Vet-Report   
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2. AMR status in the EU and EEA 121 
Antimicrobial resistance is a serious public health threat in Europe. For invasive bacterial 122 
infections, prompt treatment with effective antimicrobial agents is especially important and 123 
this is usually the single most effective intervention to reduce the risk of fatal outcome. 124 
Ongoing increase of antimicrobial resistance in invasive bacterial isolates according to the 125 
report by European Antimicrobial Resistance Surveillance Network / EARS-Net (EARS, 126 
2014) to a number of key antimicrobial groups (3rd and 4th generation of cephalosporins, 127 
fluoro- and other-quinolones, glycopeptides, macrolides and ketolides), as well as penicillin’s 128 
and aminoglycosides to a certain degree (WHO, 2011b), is of great concern and should be 129 
considered as the highest priority. The antimicrobial resistance situation in Europe shows 130 
large variations depending on the bacterium, antimicrobial group and geographical region 131 
(ECDC, 2014). These variations between the EU Member States (MSs) and EEA countries 132 
(Norway, Iceland and Switzerland) might be also due to the lack of uniformity in sampling 133 
schemes, laboratory methods used for identification of AMR profile, approach regarding 134 
clinical breakpoints (clinical resistance) and epidemiological cut-off values (microbiological 135 
resistance), as well as defined priorities regarding public health impact. To overcome this 136 
issue, the `Zoonoses Directive` (EU, 2003a) was issued, to support the harmonization of 137 
national monitoring and surveillance schemes for foodborne diseases, including AMR. The 138 
importance of protecting human health against diseases and infections transmissible directly 139 
or indirectly between animals and humans (zoonoses) was stressed, including foodborne 140 
zoonoses. It implies that EU MSs shall ensure that integrated data on the occurrence of 141 
zoonoses and zoonotic agents and related antimicrobial resistance in animals, food and 142 
humans are collected, analysed and published without delay (Figure 1). However, up to the 143 
time of writing this article, substantial differences exists between the MSs regarding specific 144 
aspects in implementation of national monitoring and surveillance systems for zoonotic 145 
foodborne pathogens and AMR, which create certain difficulties in interpreting and 146 
extrapolating data between MSs. 147 
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  148 
Figure 1. Number of Member States’ submissions of antimicrobial resistance in zoonotic 149 
(Campylobacter, Salmonella, MRSA) and indicator bacteria (E. coli, Enterococcus) in 150 
animals, food and humans (Adapted from EFSA/ECDC, 2015) 151 
 152 
2.1. AMR in Humans 153 
The first concerns about antimicrobial resistance in humans were raised in Denmark, in 1994 154 
and 1995, due to usage of the growth promoting antimicrobial (avoparcin). This led to the 155 
occurrence of vancomycin resistant Enterococcus faecium in humans (Bates et al., 1994; 156 
Aarestrup, 1995). During this period of time, there was also a growing awareness and a 157 
general public concern about overuse of antibiotics in Danish pig and poultry production and 158 
the effects on antimicrobial resistance.  159 
In France, a comprehensive study was conducted to define the antimicrobial profiles and 160 
patterns related to Campylobacter-associated infections in humans and to compare this with 161 
Campylobacter isolated from broiler chicken and pigs (Gallay et al., 2007). The database 162 
originated from 1986-1990 was compared with trends from 1999-2004; it was reported that 163 
resistance to nalidixic acid increased dramatically (3 fold), while the patterns of resistance to 164 
quinolones and fluoroquinolones for C. jejuni were similar between 1999 and 2004, in human 165 
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and broiler isolates. Skurnik et al. (2006) carried out a study to determine the level of 166 
antimicrobial resistance in E. coli of animal faecal origin in several animal populations with 167 
different exposure to human contact (wild animals, farm animals and pets). It was proven that 168 
occurrence of antimicrobial resistance in E. coli isolated from animal faecal material 169 
happened due to anthropogenic influence. Obviously, the emergence, development and 170 
spread of antimicrobial resistance is a dynamic process flowing into both directions - 171 
zoonotic impact (animal/food-human) and anthropogenic (humans-animals). French Agency 172 
for Food, Environmental and Occupational Health & Safety released a report on the usage of 173 
colistin (ANSES, 2015), an antibiotic used in veterinary medicine (in livestock), which is also 174 
of the highest importance in human medicine. Due to its toxicity, colistin is only prescribed 175 
for the treatment of severe human infections involving bacteria resistant to all other 176 
therapeutic options (including bacteria resistant to last-generation cephalosporins and 177 
carbapenems). Initially, it was considered that colistin, because of the absence of any 178 
mechanism for transferring resistance to this antibiotic between bacteria, shouldn`t be 179 
included in the list of critically important antibiotics used in veterinary medicine. However, 180 
in 2015, the first transferable mechanism for resistance to colistin (the mcr-1 gene) was 181 
described in China in pigs and chickens, in meat sold at retail, and also among bacterial 182 
strains isolated in humans. European Medicines Agency recommended additional monitoring 183 
of off-label use of colistin and restrictions on indications to therapy or metaphylaxis and 184 
removing all indications for prophylactic to minimise any potential risk associated with a 185 
broader use (EMA, 2016); consequently ANSES revised its risk assessment and included the 186 
colistin in the list of veterinary antibiotics of critical importance.  187 
In Netherlands, the epidemiological link of antimicrobial resistance between animals and 188 
humans was investigated in an integrated study carried out by van den Boggard and 189 
Stobberingh (2000); it was concluded that use of antibiotics in food animals may provoke the 190 
emergence and dissemination of resistant bacteria. It is observed that the level of resistance of 191 
pathogenic foodborne bacteria (Salmonella, Campylobacter) and commensal bacteria (E. coli, 192 
Enterococcus) increases after the introduction of antibiotic. It is known that commensal 193 
bacteria are a reservoir of resistance genes for pathogenic (foodborne) bacteria. Their level of 194 
resistance may serve as a good indicator for selection pressure from antibiotic usage and for 195 
prediction of resistance in pathogens. Monitoring of resistance in indicator bacteria 196 
(Escherichia coli and enterococci) in different ecological compartments, e.g. in environment 197 
(manure, water, feed), animals, food of animal origin (meat), patients and healthy humans, 198 
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should provide valuable data on resistance prevalence and facilitate the understanding of the 199 
resistance transfer from animals to humans and vice versa.  200 
In a study carried out in Sweden from 2000-2004, genetic characterization of Campylobacter 201 
isolates associated with antimicrobial resistance was conducted to provide better 202 
understanding of epidemiological link between AMR in humans, meats and water. This study 203 
confirmed the link between meat consumption and antimicrobial resistance in humans and 204 
also enabled focusing on identification and eradication of the major reservoirs with common 205 
clones of the public health importance (Lindmark et al., 2004).  206 
In Norway, the study carried out from 1975-1998, revealed the emergence of multi-resistant 207 
Salmonella Typhimurium DT104 isolates collected from humans; the first multi-resistant 208 
isolate appeared in 1994, while in 1998 already 23% of domestically acquired isolates were 209 
multi-resistant (Leegard et al., 2000).  210 
Significant increase in the rate of gram-negative microorganisms isolated from humans 211 
(blood and cerebrospinal liquor), as well as foodstuffs had been observed in EU, from 2011-212 
2014 (ECDC, 2014).  Additionally, a possible relationship between antimicrobial usage in 213 
food animals and the occurrence of AMR in humans was conducted (ECDC, 2015). 214 
It is estimated that 11,381.8 tonnes of active substance with antimicrobial effect was used in 215 
humans and food animals in 26 EU/EEA countries in 2012 (ECDC/EFSA/EMEA, 2015) 216 
(Figure 2).  217 
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218 
Figure 2. Comparison of biomass-corrected consumption of antimicrobials (mg/kg) in 219 
humans and food-producing animals by 26 EU/EEA countries in 2012 (Adapted from 220 
ECDC/EFSA/EMEA, 2015) 221 
A resistance to third-generation cephalosporin’s in Klebsiella pneumoniae and Escherichia 222 
coli increased significantly at EU/EEA level as well as in many of the individual MSs. 3rd 223 
generation cephalosporin resistance was often associated with fluoroquinolone and 224 
aminoglycoside resistance. Resistance trends in gram-positive bacteria showed a more 225 
diverse pattern across Europe. The percentage of EU/EEA population from which the 226 
methicillin-resistant Staphylococcus aureus (MRSA) was isolated, continued to decrease over 227 
the last four years, from 18.6 % to 17.4 % in 2011 and 2014, respectively. The significantly 228 
increasing four-year trend for vancomycin resistance in Enterococcus faecium (commensal 229 
microorganism) was observed from 2013. EU data regarding AMR for Salmonella in humans 230 
indicated increased resistance associated with ampicillin, cefotaxime, chloramphenicol, 231 
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ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulphonamides, 232 
tetracycline’s and trimethoprim. The AMR reported for Campylobacter was mainly 233 
connected with amoxicillin, ampicillin, ciprofloxacin, erythromycin, gentamicin, nalidixic 234 
acid and tetracycline (EFSA, 2011). These findings are closely related to the prevailing use of 235 
certain class of antibiotics in selected EU and EEA countries (Table 3). 236 
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Table 3. Most commonly used antimicrobials in selected EU/EEA countries  237 
Country Programme Cattle Pigs Poultry Combined cattle, pigs 
and poultry  
Food producing animal 
consumption in tonnes active 
(ECDC/EFSA/EMEA, 2015) 
Denmark  
 
DANMAP 1. Penicillin’s b-Lactase 
sensitive 
2. Tetracycline’s 
3. Sulphonamides and 
Trimethoprim 
1. Tetracycline’s 
2. Penicillin’s b-Lactase 
sensitive 
3. Macrolides 
1. Tetracycline’s 
2. Macrolides 
3. Penicillin’s (others) 
 
N/A** 
107 tonnes 
France 
 
 
RESAPATH N/A* N/A* N/A* 1. Tetracycline’s,  
2. Sulphonamides,  
3. Penicillin’s,  
761.5 tonnes 
The Netherlands     MARAN 1. Penicillin’s 
2. Combinations 
3. Tetracycline’s 
1. Tetracycline’s 
2. Penicillin’s 
3. Trimethoprim/ 
Sulphonamides 
1. Macrolides / 
lincosamides 
2. Quinolones 
3. Polymixins 
 
N/A** 245.7 tonnes 
Sweden 
 
 
    SVARM N/A* N/A* N/A* 1. Benzyl penicillin 
2. Sulphonamides 
3. Tetracycline’s 
10.6 tonnes 
Norway NORM-VET    1. Penicillin’s 
2. Sulphonamides 
3. Aminoglycosides 
7.1 tonnes 
* Breakdown of antimicrobials for individual species unavailable  238 
**Breakdown of antimicrobials for combined species unavailable239 
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 240 
2.2. AMR in Food (Meat) Animals 241 
Development and increase of AMR in humans has a connection with antibiotic use in another 242 
ecological compartment – food animals. Therefore, the Member States (MSs) of the EU 243 
followed a monitoring system since 2003 (EU, 2003a; Directive 2003/99/EC that sets rules for 244 
monitoring on AMR and provides Member States, a. to ensure that monitoring provides 245 
comparable data on the occurrence of AMR in zoonotic agents and b. to assess the trends and 246 
sources of AMR in their territory). In 2013, based on the proposals issued by EFSA, the 247 
European Commission put forward and discussed with the MSs a new legislation on the 248 
harmonised monitoring of antimicrobial resistance in zoonotic (Salmonella, Campylobacter) 249 
and commensal bacteria (Escherichia coli and Enterococcus spp.) in food-producing animals 250 
and food; a list of combinations of bacterial species, food producing animal populations and 251 
food products was defined, panel of antimicrobials and tests to be used are recommended and 252 
priorities for the monitoring of antimicrobial resistance from a public health perspective were 253 
set up (EU, 2013; Commission Decision 2013/652/EC on the monitoring and reporting of 254 
antimicrobial resistance in zoonotic and commensal bacteria). Such approach should provide 255 
better consistency between EU MSs, regarding sampling, method of susceptibility testing and 256 
reporting, as well as improve the comparability of the data generated among MSs. 257 
A comprehensive study of AMR in bacteria isolated from food animals to antimicrobial 258 
growth promoters and therapeutic agents was carried out in Denmark, in 90’s (Aarestrup et 259 
al., 1998). The acquired resistance to all used growth promoting antimicrobials was 260 
confirmed, with most frequent occurrence of resistance observed to avilamycin, avoparcin, 261 
bacitracin, flavomycin, spiramycin, tylosin and virginiamycin.  The occurrence of resistance 262 
varied according to animal origin and bacterial species. The highest levels of resistance were 263 
observed among indicator bacteria (enterococci), while less resistance was observed among 264 
pathogenic zoonotic bacteria (Salmonella, Campylobacter). Similarly like in other EU MSs, 265 
the thermo-tolerant Campylobacter was the most commonly reported pathogen associated 266 
with gastrointestinal bacterial infections in humans. Broilers are identified as the primary 267 
source of infection, though other sources may also exist, e.g. water from untreated water 268 
sources and other infected animals. The particular resistance found in C. jejuni isolates was to 269 
ciprofloxacin and nalidixic acid. Among the Salmonella isolates (S. Typhimurium and S. 270 
Derby) from healthy Danish pigs, relatively high levels of resistance (34% - 49%) were 271 
observed to ampicillin, sulphonamide, and tetracycline (DANMAP, 2014). In indicator 272 
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bacteria (enterococci), a high level of resistance in Enterococcus faecalis isolated from 273 
broilers was observed to tetracycline (49%), followed by erythromycin (27%) and 274 
chloramphenicol (2%).  Parallel to that, a very high occurrence of resistance to tetracycline 275 
(83%) and moderate to high occurrence of resistance to erythromycin (49%) and 276 
chloramphenicol (24%) was found in E. faecalis isolates from pigs. The occurrence of 277 
resistance to tetracycline has increased over the last five years, which may lead to the 278 
increase of potential risk of spreading the antimicrobial resistance, via horizontal gene 279 
exchange, to other pathogenic bacteria (DANMAP, 2014). 280 
In France (RESAPATH, 2012) it is estimated that the resistance level in S. Typhimurium 281 
isolated from cattle is very high, especially to amoxicillin (89%), tetracycline (92%) and 282 
sulphonamides (72%). The resistance level in E. coli isolated from pigs was extremely high 283 
to amoxicillin (97%), gentamycin (94%), tetracycline (98%), enrofloxacin (94%) and 284 
trimethoprim-sulphonamides (97%). In hens and broilers, the extreme level of resistance in E. 285 
coli was confirmed to amoxicillin (98%), ceftiofur (97%), gentamycin (96%), tetracycline 286 
(98%), flumequine (97%), enrofloxacin (97%) and trimethoprim-sulphonamides (97%). 287 
In Netherlands, the antimicrobial resistance detected in S. Typhimurium was predominantly 288 
associated with pigs, but was also found (although less predominant) in cattle and poultry. 289 
Resistance of S. Enteritidis was mainly present in poultry and more specifically in laying 290 
hens and contaminated eggs, while resistance in S. Dublin was observed mainly in cattle 291 
(MARAN, 2013).The highest resistance levels of C. jejuni isolated from poultry were 292 
observed for tetracycline and the quinolones (ciprofloxacin and nalidixic acid) raising a 293 
public health concern, and much lower in isolates from laying hens. However, resistance to 294 
macrolides, e.g. erythromycin, the first choice antibiotic in human infections (critically 295 
important antibiotic), was still low. This is in line with finding that macrolide resistance was 296 
not detected in C. coli from pig meat. Surveillance in indicator bacteria (E. coli) showed 297 
resistance to ampicillin, tetracycline’s, sulphonamides and trimethoprim and it was 298 
commonly detected in broilers, turkey, pigs and veal calves. Although resistance to 299 
fluoroquinolones decreased, it was still commonly present in indicator E. coli from poultry 300 
sources. The promising results were reported regarding resistance to 3rd generation 301 
cephalosporins (critically important antibiotics) which was low in most animal species. 302 
Susceptibility testing of enterococci is considered of lesser priority than E. coli and from 303 
2013 and onwards poultry, pigs and cattle are sampled every three years instead of annually 304 
(MARAN, 2013).  305 
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In Sweden, the majority of submissions for testing on antimicrobial resistance originated 306 
from clinical samples associated with diseased animals. Therefore, data may be biased taking 307 
into consideration the samples from treated animals or from herds where antibiotic treatment 308 
is common, versus clinically healthy animals where antimicrobial treatments were rare. 309 
Isolates are classified as susceptible or resistant by Epidemiological Cut Off Values 310 
(ECOFFs) issued by European Committee of Antimicrobial Susceptibility Testing 311 
(EUCAST). In E. coli, clinical samples from pigs, taken on-farm (faeces) or post-mortem 312 
(faecal material from intestines), the resistance to streptomycin (50%), trimethoprim-313 
sulphamethoxazole (46%), ampicillin (40%) and tetracycline (25%) was the most common 314 
trait. Multi-resistance occurred in 42% (50/118) of the isolates in 2014, which is higher than 315 
in previous years (38% in 2013, 24% in 2012, 25% in 2011, 15% in 2010, 19% in 2009 and 316 
14% in 2008). The reason for this increase remained uncertain. In E. coli samples obtained 317 
from cattle (calves no more than a few weeks old, when the resistance in enteric bacteria is 318 
usually high) during the period 2012-2014, resistance was higher than in previous years for 319 
streptomycin (42%), tetracycline (31%) and ampicillin (24%). Multi-resistance occurred in 320 
76% (22/29) of the isolates from 2014, compared to 70% in 2013, 50% in 2012 and 40% in 321 
2007-2011. In broilers, laying hens and turkeys, the occurrence of ESBL-producing E. coli 322 
from faeces and environment is monitored and the epidemiology of this resistance is studied. 323 
The majority of isolates (75%) were susceptible to all antibiotics tested (SVARM, 2014). 324 
In Norway, the situation regarding antimicrobial resistance to Salmonella spp. in food 325 
animals is very good since those animal populations are almost free from Salmonella spp. 326 
To maintain this favourable situation, Norway runs an extensive surveillance programme that 327 
covers both live animals (cattle, pigs and poultry) and meat samples (NORM-VET, 2013). 328 
However, in 2013, the resistance to fluoroquinolones was found in S. Virchow from pig, 329 
while the multi-resistant S. Typhimurium was isolated from one pig herd (resistance to 330 
tetracycline, ampicillin, sulfamethoxazole and streptomycin). The isolates of Campylobacter 331 
jejuni in broilers were obtained from caecal samples and all broiler flocks slaughtered before 332 
50 days of age were tested for the presence of Campylobacter spp. In 2013, one C. jejuni 333 
isolate per positive flock (total of 96 flocks) was submitted for susceptibility testing. The 334 
highest rate of resistance was detected for fluoroquinolones (ciprofloxacin [5.2%], nalidixic 335 
acid [5.2%]), tetracycline (3.1%) and streptomycin (2.1%). These findings confirmed that the 336 
prevalence of antimicrobial resistance among C. jejuni isolates from Norwegian broilers is 337 
low. This is also in line with common practice in Norwegian poultry flocks where therapeutic 338 
use of antimicrobial agents in broilers is relatively low and the products applicable for such 339 
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use contain either amoxicillin or phenoxymethylpenicillin; nalidixic acid is not used in 340 
poultry at all. Escherichia coli and Enterococcus spp. are monitored as indicator bacteria. E. 341 
coli isolates were obtained from samples from a total of 204 layer flocks and 131 turkey 342 
flocks; the highest resistance was found to tetracycline (12.8% and 7%, respectively), 343 
ampicillin (9.2% and 12.8%, respectively), sulfamethoxazole (11.3% and 9.2%, respectively), 344 
trimethoprim (5.9% and 3.7%, respectively) and streptomycin (4.3% and 4.6%, respectively). 345 
It is known that acquired resistance to cephalosporins among gram negative bacteria (e.g. E. 346 
coli) has called on special attention in recent years. Production of extended-spectrum beta-347 
lactamases (ESBLs) or transferable AmpC are major mechanisms behind such resistance 348 
(Babic et al., 2006). ESBL producing E. coli were not detected in any of the 204 samples 349 
taken from layer flocks, indicating prevalence below 1.8%. However, the results from the 350 
broiler production revealed very high resistance to 3rd generation cephalosporin’s (43%). In 351 
E. faecalis, the resistance was determined from samples taken from layers and turkey; the 352 
highest level of resistance was found in tetracycline (31.5% and 41.5%, respectively), 353 
erythromycin (10.1% and 18.2%, respectively), bacitracin (3.3% and 18.2%, respectively) 354 
and narasin (1.1% and 12.1%, respectively).   355 
2.2.1. Meat/Meat products.  356 
The occurrence of antimicrobial resistance associated with bacteria found on/in meat/meat 357 
products was investigated in many studies carried out in European countries.  358 
In Denmark, Andersen et al. (2006) conducted a study to determine the antimicrobial 359 
resistance of Campylobacter jejuni in raw poultry meat at retail level. The highest level of 360 
resistance was reported to tetracycline, nalidixic acid and ciprofloxacin, while low resistance 361 
was observed to macrolides (antibiotics important for human health). Wielinga et al. (2014) 362 
conducted a study to evaluate the evidence-based policy to control antimicrobial resistance in 363 
the food chain. They investigated the conflict of interest between the major stakeholders from 364 
agriculture, veterinary, health and commercial level and concluded that success of the 365 
national surveillance and monitoring programmes can be only achieved if all stakeholders, 366 
from farm-to-fork, are involved. 367 
In France, Granier et al. (2011) conducted a review to assess AMR in Listeria 368 
monocytogenes, in food and environmental isolates, from 1996 to 2006. More than two 369 
hundred strains were collected and selected on the basis of a unique pulsed-field gel 370 
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electrophoresis (PFGE) profile. Half of the strains were isolated from food samples and a 371 
quarter from food processing plants. Out of the total number of isolates, 20% belonged to 372 
meat (pork, 10%; poultry, 5%; and beef, 5%) while other originated from dairy and sea 373 
products. Resistance to erythromycin, tetracycline-minocycline, and trimethoprim was 374 
reported. Further, a comprehensive one-year study was carried out to establish prevalence and 375 
characterization of Campylobacter jejuni in retail chicken meat in French outlets (Guyard-376 
Nicodeme et al., 2015). Campylobacter was detected in 76% of collected samples and 377 
resistance to tetracycline was the most common (53.6%), followed by ciprofloxacin (32.9%) 378 
and nalidixic acid (32%). All tested isolates were sensitive to erythromycin, chloramphenicol 379 
and gentamycin. 380 
In Netherlands, Bruin et al. (2010) reported on prevalence and quantity of highly resistant 381 
Enterobacteriaceae (HRE), including ESBLs, in retail meat. The tested retail meat samples 382 
were chicken (52%), beef (29%), pork (9%), and other sources (9%). The ESBL producing E. 383 
coli was recovered from 18% of tested samples and all ESBL positive samples were chicken 384 
(34% positive). Resistance levels were very high to ampicillin (98%) and 385 
amoxicillin/clavulonic acid (80%), and low to cotrimoxazole (7%), gentamicin (5%), while 386 
resistance wasn`t observed to piperacillin/tazobactam, meropenem and ciprofloxacin. Since 387 
majority of tested chicken meat samples were ESBL positive it is concluded that chicken 388 
meat is a potential source of pandemic ESBL producing E. coli in the community and 389 
hospitals. Overdevest et al (2011) also confirmed the high prevalence of ESBL producing E. 390 
coli in retail chicken meat (79.8%). Genetic analysis showed that the predominant ESBL 391 
genes in chicken meat and human rectal swab specimens were identical. These findings 392 
implied that the role of ESBLs in chickens and its possible transmission to humans should be 393 
further investigated and clarified. Since it is well-known that restrictive use of antibiotics may 394 
result in lower resistance rates, Van der Broucke-Grauls (2014) speculated how powerful 395 
restrictive use should be to minimize the rise of antimicrobial resistance? The author gives an 396 
opinion that the resistance to antimicrobials in the future will slowly continue to rise, in spite 397 
of restricted use of antimicrobials since recently. It was concluded that the emergence of 398 
antimicrobial resistance is clearly of multi factorial nature and it is still uncertain what are the 399 
main contributors leading to this phenomenon. In Netherlands, a movement toward lower 400 
antibiotic use in animal husbandry already started. The use of 3rd generation cephalosporins 401 
was completely stopped in broilers and pigs, in March 2010. The promising results were 402 
reduction in resistance in E. coli from chicken, pigs, and calves. The future will bring the 403 
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answer whether this change is sufficient to slow down the rising resistance in humans (Van 404 
der Broucke-Grauls, 2014). 405 
In Sweden, Ge et al. (2003) conducted a study to determine antimicrobial resistance in retail 406 
chicken meat. They reported that around 94% of tested meat samples were contaminated with 407 
Campylobacter strains that were resistant to at least one of seven antimicrobials in the panel. 408 
The resistance to tetracycline was the highest (82%), followed with doxycycline (77%), 409 
erythromycin (54%), nalidixic acid (41%) and ciprofloxacin (35%). Egervarn et al. (2014) 410 
studied the prevalence of E. coli, with transferable ESBL and AmpC beta-lactamases, and 411 
Salmonella on meat imported into Sweden (imported pork, beef and broiler meat). The 412 
authors highlighted that increased occurrence of Enterobacteriaceae (including E. coli) with 413 
transferable ESBL/AmpC beta-lactamases in humans may be linked with food (meat) 414 
producing animals. The prevalence of ESBL/AmpC-producing E. coli was 2-13% in pork 415 
meat, 0-8% in beef and 15-95% in broiler meat. Interestingly, the highest prevalence of 416 
ESBL/AmpC-producing E. coli was reported in South American broiler meat (95%), 417 
followed by broiler meat from Europe, (excluding Denmark) (61%) and from Denmark 418 
(15%). The results of the study implicated that meat imported into Sweden may present a 419 
significant source of human exposure to ESBL/AmpC-producing E. coli. This is particularly 420 
important since the ingestion of this organism by consumers may lead to transfer of resistance 421 
genes (blaCTX-M-2 and blaCTX-M-8), via conjugation, to another bacterium, including those with 422 
human pathogenic potential. Yavari (2012) carried out a comprehensive review in Sweden, 423 
selected European countries and USA on antibiotic resistance in Salmonella enterica, 424 
emphasizing the role of food animal control.  A success of national monitoring and 425 
surveillance programme for control of AMR in Sweden is a consequence of efficient policy 426 
towards controlling the antibiotic resistance by effective management and regular prevention 427 
programs, and controlling different ecological/production compartments such as feed, food 428 
animals and humans. Such policy also resulted in effective collaboration of different 429 
organization in Sweden and led to decrease in the consumption of antibiotic in animals. 430 
Subsequently, low consumption of antibiotics in animals and humans led to the low 431 
prevalence of Salmonella. The success of any disease control program lies in the 432 
effectiveness and intensity of inter-sectoral cooperation. The communication between 433 
veterinary organizations and health care providers is essential to exchange the knowledge and 434 
relevant information. The international collaboration is also needed to achieve more effective 435 
control over spread of salmonellosis and to target antibiotic resistance (Yavari, 2012).   436 
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In Norway, Mo et al. (2016a) reported that E. coli resistant to extended-spectrum 437 
cephalosporins was found in broiler production and consequently in broiler meat, in spite of 438 
the restrictive policy indicated that the usage of antimicrobials is rare. The isolates from 439 
intestinal microbiota of broilers and from chicken meat in retail were compared to establish 440 
the epidemiological link via clones and resistance plasmids. Interestingly, it was revealed that 441 
clonal expansion via horizontal transfer, supported with stability of plasmid containing 442 
blaCMY-2, is maintained and disseminated within the broiler farms in Norway despite the 443 
absence of selective pressure due to low use of antimicrobials. In subsequent study Mo et al. 444 
(2016b) investigated the risk factors for occurrence of cephalosporin-resistant E. coli in 445 
Norwegian broiler flocks. The authors concluded that implementation of a high level of 446 
biosecurity is of crucial importance for decrease in the occurrence of cephalosporin-resistant 447 
E. coli in broiler flocks. The most important biosecurity risk factors were to minimize the 448 
number of people entering the broiler house during production cycles, as well as rigorous 449 
cleaning and disinfection routines between production cycles. These measures could result 450 
with decrease of resistance only if there is no selection pressure from antimicrobial use in the 451 
broiler production.  452 
 453 
2.3. Sampling plans 454 
Monitoring of antimicrobial resistance in EU MSs should be based on isolates obtained from 455 
clinical samples regularly submitted to a diagnostic laboratory or on actively collected 456 
isolates from healthy or diseased animals and meat products in all production stages: 1) pre-457 
harvest (farm), 2) harvest (abattoir) and 3) post-harvest (retail) (EFSA, 2008, 2014b). The 458 
selection of isolates from clinical infections usually depends on the submission of samples 459 
taken on farm from local veterinarian, while sampling at slaughterhouse and retail will 460 
usually depend on regular visits by competent authority according to the national plan for 461 
AMR monitoring and surveillance.  462 
2.3.1. Pre-harvest (on farm) 463 
The objective of AMR monitoring is to collect and test for antimicrobial susceptibility of at 464 
least 170 representative Salmonella spp. isolates obtained respectively from the populations 465 
of laying hen flocks, broiler flocks and fattening turkey flocks in the MS, on a yearly basis 466 
(Salmonella National Control Programme/NCP); the sampling should be carried out either by 467 
the Competent Authority (CA) or under its supervision, by the Food Business Operator 468 
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(FBO). In addition, FBO should take the responsibility to submit for susceptibility testing the 469 
Salmonella strains which are randomly selected and originate from different (positive) flocks 470 
and, optimally, from different farms.  471 
Two sampling approaches are suggested: 1) a stratified sampling strategy, e.g. proportional 472 
allocation within a sampling frame of Salmonella spp. strains deriving from the isolate 473 
collections available from the official laboratories and/or other laboratories designated by the 474 
CA, and 2) a simple random sampling (SRS), e.g. within the sampling frame of flocks 475 
involved in the NCP and which have tested positive for Salmonella.  It is suggested to design 476 
the sampling plan as a quarterly SRS of the flocks tested positive for Salmonella. 477 
2.3.2. Harvest (at abattoir) 478 
The objective is to collate and test for antimicrobial susceptibility of at least 170 479 
representative isolates of Salmonella spp. obtained respectively from carcasses of broilers, 480 
fattening turkeys, fattening pigs and bovines under 1 year of age. A collection of 481 
representative caecal samples (the number to be determined in each MS according to the 482 
estimation of the annual production) should be conducted to obtain isolates as follows: E. coli 483 
from broilers, fattening turkeys, fattening pigs and bovines under 1 year of age; 484 
Campylobacter jejuni from broilers and fattening turkeys; and isolates of Extended Spectrum 485 
Beta-Lactamase (ESBL)-/AmpC-/carbapenemase-producing E. coli from broilers, fattening 486 
turkeys, fattening pigs and bovines under 1 year of age. Under voluntary basis, the isolates of 487 
E. faecium and E. faecalis (indicator organisms) may be also taken from broilers, fattening 488 
turkeys, fattening pigs and bovines under 1 year of age, as well as isolates of Campylobacter 489 
coli from broilers and fattening pigs. 490 
2.3.3 Post-harvest (retail meat) 491 
The objective is to collect 300 representative random samples of fresh meat of broilers, pig 492 
meat and bovine meat, respectively and to test them for the presence of ESBL-/AmpC-493 
/carbapenemase-producing isolates of E. coli. In case a MS has a lower level of meat 494 
production on a yearly basis, e.g. production of less than 100 000 tonnes of poultry meat per 495 
year, less than 100 000 tonnes of pig meat per year and less than 50 000 tonnes bovine meat 496 
per year, 150 samples of fresh pig, bovine and broiler meat should be tested at retail, instead 497 
of 300 samples. A `retail` means an outlet selling directly to the final consumer for domestic 498 
consumption, e.g. outlets/supermarkets, specialist shops and markets, but excluding catering 499 
activities, restaurants and wholesalers. 500 
The sampling design is based on a proportionate stratified sampling scheme at the MS level. 501 
The samples are allocated proportionally to the size of the human population in the regions 502 
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accounting for at least 80 % of the national population. At the second level, the sampling 503 
should be conducted at retail outlets. At the third level, samples within the different meat 504 
categories should be selected. The 300/150 samples (of each meat category) should be 505 
allocated in proportion to the size of the human population. 506 
In Denmark, sampling for Salmonella spp. includes isolates from healthy pigs (caecum 507 
samples) and pork (carcass swabs) collected at abattoirs as part of national surveillance and 508 
control programmes, as well as from human cases. The structured surveillance programme of 509 
antibiotic resistance to Salmonella in Danish pigs and pork started from 2011. Salmonella 510 
isolates from broiler, layer hens and cattle farms, as well as isolates from other types of meat 511 
(Danish and imported) are not presented. Interestingly, the monitoring and surveillance plan 512 
include only resistance among S. Typhimurium since the numbers of poultry flocks and meat 513 
samples infected or contaminated with S. enteritidis decreased over the last ten years 514 
(DANMAP, 2014). For Campylobacter, randomly collected samples are taken from broilers 515 
and cattle at slaughter and from fresh broiler meat ready for retail. Isolates from human cases 516 
originate from three out of five geographical regions in Denmark. The results for resistance 517 
profile of Campylobacter jejuni in Denmark indicated that 85-95% of the human 518 
campylobacteriosis cases are caused by C. jejuni. For Enterococci, a random collection of 519 
Enterococcus isolates from healthy pigs and broilers at slaughter (E. faecalis only) and from 520 
domestic fresh broiler meat, pork and beef sold at wholesale and retail outlets (both E. 521 
faecalis and E. faecium) was conducted. Enterococci (E. faecalis) from imported broiler 522 
meat, beef and pork were also included. Only one isolate per farm or meat sample is included 523 
in the final report. There are no specific sampling plans for testing of Extended Spectrum 524 
Beta-Lactamase (ESBL)-/AmpC-/carbapenemase-producing E. coli from broilers, fattening 525 
turkeys, fattening pigs and bovines. 526 
In France, the collection of samples for AMR survey in bacteria isolated from the food chain 527 
is carried out by the French Agency for Food Safety (AFSSA, Paris). To assess a risk for 528 
emergence and dissemination of antimicrobial resistance between ecological compartments, 529 
and consumers, the sampling is conducted in animals, food and environment. The collection 530 
of samples is carried out in such a way that data may be compared between these 531 
compartments, at national and international level. Two types of epidemiological surveillance 532 
networks have been set up. The first type is based on gathering Salmonella zoonotic strains in 533 
AFSSA where they are systematically tested for their antimicrobial susceptibility (Martel et 534 
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al., 2000). Salmonella strains isolated from environment, food producing animal and food are 535 
collected under the `Salmonella Network` programme, which is targeted national 536 
epidemiological surveillance system set up to monitor non-human Salmonella throughout the 537 
food chain. The network was officially created in 1997 and today includes nearly 150 public 538 
and private veterinary laboratories in 94 departments across France. The second type of 539 
surveillance is managed by AFSSA and serves as a multi-centric system to collect antibiotic 540 
susceptibility data on pathogenic strains isolated in local public veterinary diagnostic 541 
laboratories. Each network has been designed for one particular type of investigation. Data on 542 
AMR are summarized in French surveillance network for antimicrobial resistance in 543 
pathogenic bacteria of animal origin which started from 1982 (firstly in bovines) and 544 
nowadays in called `RESAPATH`. From 2000, the surveillance system was expanded to pigs 545 
and poultry and, in 2007, to other animal species such as small ruminants, companion 546 
animals or horses (RESAPATH, 2012). However, there is no specific information on 547 
sampling plans employed in this national programme, except that sampling will encompass 548 
harvesting of faeces or caeca from diseased animals, on farm and/or abattoir. Commensal 549 
bacteria (E. coli, Enterococcus faecium) and zoonotic strains (Campylobacter spp. and some 550 
Salmonella isolates) are isolated according to type: bovine, porcine, or avian. 551 
In Netherlands, sampling is implemented according to national plan for monitoring of AMR 552 
and antibiotic usage in animals (MARAN, 2013). Sampling strategy has a goal to obtain 553 
annual collections of E. coli and Salmonella enterica, representative of the Dutch food-554 
producing animal bacterial populations, including isolates obtained from retail. The samples 555 
are regularly taken from poultry populations on farm (the faecal samples) and/or abattoir 556 
(caecal samples), as well as poultry meat at retail (Leverstein-van Hall et al., 2011). 557 
Additional data on sampling plan were not available in Dutch national plan. Further, the 558 
Dutch approach to AMR encompasses all ecological compartments where human health is 559 
threatened by antibiotic resistant bacteria, e.g. healthcare sector, food producing animals, 560 
food and environment. This is an integrated approach based on the `One Health` concept. The 561 
main focus lies in healthcare and food-producing animals because the emergence and spread 562 
of antibiotic resistant bacteria starts from food-producing animals and subsequent transfer to 563 
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humans; the healthcare settings may be also environments where the transfer of resistance 564 
genes due to excessive use of antibiotics may be facilitated. 565 
In Sweden, the sampling is carried out to cover all respective sectors - animal, food and 566 
humans. The collected samples are tested in designated public health laboratories coordinated 567 
by the Public Health Agency of Sweden and veterinary/food laboratories coordinated by the 568 
National Veterinary Institute. The results are jointly interpreted and reported in an integrated 569 
manner by both institutions (SVARM, 2014). Clinical isolates are taken from food-producing 570 
animals (on farm), e.g. pigs, cattle and sheep, and from humans (isolates from blood culture). 571 
Information on the indication for sampling was not available for many samples and the 572 
majority of submissions were likely from animals with disease. Therefore, data may be 573 
biased towards samples from treated animals or from herds where antibiotic treatment is 574 
common. 575 
In Norway, the sampling of indicator organisms (Escherichia coli and Enterococcus spp.), 576 
which form the normal enteric microbiota, is carried out to determine the prevalence of 577 
acquired antimicrobial resistance. This can be used as an indicator of the selective pressure 578 
from use of antimicrobial agents in various populations. These bacteria may form a reservoir 579 
of transferable resistance genes from which antimicrobial resistance can be spread to other 580 
bacteria, including those responsible for infections in animals or humans. Faecal samples are 581 
taken via boot swabs from layer flocks and from turkey, including ESBL-producing E. coli 582 
from turkey fillets at retail. The sampling of isolates of zoonotic food borne pathogens, e.g. 583 
Salmonella spp., Campylobacter spp., Yersinia enterocolitica and non-zoonotic pathogen - 584 
Shigella spp. is also conducted. Human clinical isolates are collected from blood, urine and 585 
cerebrospinal fluid. The sampling plan is carried out according to provisions given in 586 
Regulation 652/2013/EC on the monitoring and reporting of antimicrobial resistance in 587 
zoonotic and commensal bacteria. Salmonella spp. isolates are taken from each population of 588 
laying hens, broilers and fattening turkeys sampled in the framework of the national control 589 
programmes (EU, 2003b); carcasses of broilers, fattening turkeys, fattening pigs, and bovines 590 
under one year of age, are also collected. Campylobacter jejuni isolates are collected from 591 
caecal samples gathered at slaughter from broilers and from fattening turkeys. 592 
 593 
2.4. Antimicrobial susceptibility testing 594 
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Susceptibility testing aims to quantify drug potency against specific pathogenic bacteria and 595 
to establish what measures can be taken to safely formulate the drug so it is a viable option 596 
for therapeutic treatments. It is also used to establish if changes in pathogenic behaviour 597 
against already tested drugs is occurring due to microbial resistance. When EUCAST defines 598 
a microorganism as “susceptible” this generally means that the microorganism is susceptible 599 
to the therapy and that success when this specific antimicrobial agent is used is high. The 600 
opposite is defined when the microorganism is resistant to selected antimicrobial agent. 601 
When determining the ability of antimicrobials to be successful against a specific pathogen, 602 
the following information should be taken into consideration, e.g. the site of infection, ability 603 
of antimicrobial to reach infection site, as well as formulations available and dosage regimes 604 
(EFSA/ECDC, 2016).  605 
Disk diffusion is one of the oldest approaches to antimicrobial susceptibility testing (AST) 606 
and remains one of the most widely used AST methods in routine clinical microbiology 607 
laboratories; it is very suitable for application and almost all antimicrobial agents can be 608 
tested since it requires no special equipment (Matuschek et al., 2014). Disk diffusion proved 609 
to be a reproducible and accurate method for AST if performed according to 610 
recommendations (Woods, 1995). European Committee on Antimicrobial Resistance Testing 611 
(EUCAST), with assistance from the European Society of Clinical Microbiology and 612 
Infectious Diseases (ESCMID) suggested a disc diffusion test with diameter breakpoints 613 
correlated with the EUCAST minimum inhibitory concentration (MIC) breakpoints  614 
(Matuschek et al., 2014), defined by inhibition zone diameters (IZD) expressed in mm. The 615 
MIC is used to describe the effect a new drug has on a specific organism. It identifies the 616 
minimum concentration required by an antimicrobial to inhibit the growth of an organism 617 
visually, after an overnight incubation period. It is the most widely used method for 618 
antimicrobial susceptibility testing (AST) in clinical laboratories throughout the EU/EEA 619 
(EUCAST, 2015). The disk diffusion method is widely used in France (L’Observatoire 620 
National de l’Epidémiologie de la Résistance Bactérienne aux antibiotiques/ONERBA) and 621 
Sweden (Swedish Veterinary Antimicrobial Resistance Monitoring/SVARM). 622 
Although disk diffusion is the most widely used method for measurement of antimicrobial 623 
activity against Salmonella in routine clinical laboratories, since it is inexpensive and 624 
relatively easy to perform, the dilution method (where the MIC is determined in mg/L) is a 625 
more accurate measurement than disk diffusion; it is considered as the gold standard for AST. 626 
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Therefore, for monitoring purposes the micro-broth dilution is recommended as the preferred 627 
testing method. However, there is a good to excellent correlation between the values obtained 628 
in mm and in mg/L. Validated methods of gradient strip diffusion or disk diffusion according 629 
to EUCAST protocols are also accepted. The dilution method is routinely used by Danish, 630 
Dutch and Norwegian national monitoring systems for antimicrobial resistance – DANMAP, 631 
MARAN and NORM-VET, respectively. 632 
2.4.1. Clinical breakpoints  633 
Clinical breakpoints are developed for laboratory testing on antimicrobials to determine 634 
therapeutic value against new and already developed antimicrobials. Organisms may be 635 
graded as susceptible (s) - when a micro-organism is defined as susceptible by a level of 636 
antimicrobial activity associated with a high likelihood of therapeutic success; intermediate 637 
(I) - when a level of antimicrobial agent activity is associated with uncertain therapeutic 638 
effect; and resistant (R) - when a level of antimicrobial activity is associated with a high 639 
likelihood of therapeutic failure (EUCAST, 2012).  Regardless of the method used to 640 
determine susceptibility, the purpose is to assimilate drug potency required to inhibit or kill a 641 
pathogen within the body, by using pharmacokinetics and pharmacodynamics. 642 
2.4.2. Epidemiological cut-off values (ECOFFs) 643 
Standardised epidemiological cut off values (ECOFFs) are described by the EU Reference 644 
Laboratory for Antimicrobial Resistance (EURL-AR, 2013) as “essential for the comparison 645 
of antimicrobial susceptibility monitoring results”. For the purpose of monitoring, EURL-AR 646 
recommend the use of EUCAST ECOFFs which allows categorisation of bacteria as follows: 647 
(i) wild type (for a species with the absence of acquired and mutational resistance 648 
mechanisms to the drug in question) or (ii) non-wild type (for a species with the presence of 649 
an acquired or mutational resistance mechanism to the drug in question).  650 
When bacteria are identified as having resistance, the MIC and IZD displays two major sub-651 
populations: i) one is a fully susceptible set of isolates, and ii) the other is a fully resistant 652 
population. The change to being resistant may be due to changes in the cell walls, which 653 
make it permeable and there may be the possibility of isolates to fall between resistant and 654 
susceptible. MIC testing of the isolates, after culturing, can verify the reduction in 655 
susceptibility of the pathogen to antimicrobial agents. ECOFFs are derived by testing a 656 
suitable number of isolates from a wild-type population, to ensure that an identified organism 657 
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can be treated in order to determine the likelihood of success or failure of a specific 658 
antimicrobial for clinical purposes. Accordingly, the epidemiological cut off values 659 
recommended by the EURL-AR for interpretation of AST results are defined for Salmonella 660 
spp., Campylobacter coli, Campylobacter jejuni, Escherichia coli, Staphylococcus aureus, 661 
Enterococcus faecium and E. faecalis (EURL-AR, 2013). 662 
 663 
3. Harmonization of national AMR monitoring and surveillance programmes 664 
Surveillance of antimicrobial resistance at targeted intervals or ongoing monitoring of the 665 
prevalence of resistance in bacteria from environment, food animals, food and humans is of 666 
utmost importance for food safety in the context of public health (OIE, 2016). Monitoring of 667 
bacteria from food products of animal origin intended for human consumption should be 668 
collected in different stages along the food (meat) chain, i.e. pre-harvest (on farm), harvest (at 669 
abattoir) and post-harvest (processing, packaging, storage, distribution and retail).  670 
National antimicrobial resistance monitoring and surveillance programmes should be science-671 
based and may include the following components: a) statistically based surveys (veterinary 672 
practitioners, farmers), b) sampling and testing of food animals on farm, at live animal 673 
markets and, at slaughter, c) an organized sentinel programme, e.g. targeted sampling of food 674 
animals, herds, flocks and vectors (birds, rodents), d) analysis of veterinary practice and 675 
diagnostic laboratory records, e) sampling and testing of products of animal origin intended 676 
for human consumption (OIE, 2016).  677 
Sampling strategy should be based on the characteristics of the national livestock production 678 
systems, on the basis of available information and to assess which sources are likely to 679 
contribute most to a potential risk to animal and human health. For example, sampling at pre-680 
harvest level (on farm) may encompass feed and composite faecal sample, at harvest level (at 681 
abattoir) the faecal content from the gut (ampulla recti for pigs/bovine and caecal samples for 682 
broilers), as well as swabs from carcasses to assess the overall hygiene at slaughter and the 683 
level of microbiological contamination of carcass/meat. Post-harvest level (processing, 684 
packaging, distribution and retail) should include sampling of food to assess the overall 685 
microbiological contamination from slaughter to consumer.  686 
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The monitoring of bacterial microorganisms should be focused on animal bacterial pathogens 687 
relevant to national priority to detect the emerging resistance that may pose a threat to animal 688 
and human health and to guide veterinarians in their prescribing decisions (minimizing the 689 
use of critically important antibiotics for human health). Major zoonotic foodborne pathogens 690 
(Salmonella, Campylobacter) should be monitored in food animals and feed, food of animal 691 
origin and humans. For Salmonella, serovars of public health importance should be included 692 
(S. Typhimurium and S. Enteritidis); other serovars should be also included based on the 693 
epidemiological situation in country. For Campylobacter, the most important serovars for 694 
public health should be monitored (C. jejuni and C. coli) and they should be monitored 695 
primarily from poultry and derived food products. Both, Salmonella and Campylobacter 696 
isolates should be identified to the species level and serotyped according to internationally 697 
standardised procedures, preferably at the nationally designated laboratories.  698 
Other, emerging, zoonotic pathogens may be also included in the national resistance 699 
monitoring and surveillance plan, such as methicillin-resistant Staphylococcus aureus 700 
(MRSA) and Listeria monocytogenes. 701 
The monitoring of commensal bacteria, such as E. coli and enterococci (Enterococcus 702 
faecium and Enterococcus faecalis) should be carried out in environment (farm surroundings; 703 
manure, soil, water), because they represent the natural reservoir for transfer of antimicrobial 704 
resistance genes to pathogenic bacteria, feed and food animals (the samples of gut content 705 
should be taken preferably at abattoir), food of animal origin, as well as humans; this is 706 
important in order to establish a possible epidemiological link between food animals and 707 
humans and to provide a better overview to the use and misuse of specific antimicrobial 708 
agents (Figure 3). 709 
 710 
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 729 
Figure 3. A framework of integrated monitoring and surveillance of antimicrobial resistance 730 
in the meat chain 731 
A bacterial isolate should be always preserved until the reporting is completed. Preferably, 732 
selected isolates should be permanently preserved and stored. The maintenance of database of 733 
isolates originated from the previous years may also enable the epidemiological retrospective 734 
studies. 735 
Overall, a consistency in sampling (target number of isolates per animal population and per 736 
module in the food chain, e.g. farm, abattoir, retail), method of susceptibility testing, the 737 
panel of antimicrobials and tests to be included, as well as reporting system, is of essential 738 
importance to improve the comparability of data generated between EU MSs and EEA 739 
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countries. This should be achieved by the vigorous implementation of recommendations 740 
issued by EFSA on randomised sampling for harmonised monitoring of antimicrobial 741 
resistance in zoonotic and commensal bacteria (EFSA, 2014b). Currently, a substantial 742 
differences exists between five selected EU and EEA countries regarding design and 743 
implementation of the national AMR monitoring and surveillance system (Table 4). 744 
Table 4. Comparative overview of the national AMR monitoring and surveillance systems in 745 
five selected EU and EEA countries 746 
Sampling and 
testing 
 
 
 
       Country 
†Zoonotic pathogens ♯Commensals Susceptibility 
testing 
*Food animal, matrix, 
module 
Humans Food animals Humans Disk 
diffusion 
Dilution 
method 
Denmark Salm (P, c, A; P, cs, A) 
Camp (B, A; C, A; fb, 
R) 
Salm 
Typhimurium 
(f) 
Camp  
Jejuni (f) 
Ec (P, c, A; 
C, c, A; B, c, 
A;  fb/fp/fc, 
R) 
En (P, c, A; 
B, c, A; 
fb/fp/fc, R) 
na  x 
France Salm (P, f/c, F/A; C, 
f/c, F/A; B, f/c, F/A) 
Camp (P, f/c, F/A; C, 
f/c, F/A; B, f/c, F/A) 
na Ec (P, f/c, 
F/A; C, f/c, 
F/A; B, f/c, 
F/A) 
En (P, f/c, 
F/A; C, f/c, 
F/A; B, f/c, 
F/A) 
na x  
Netherlands Salm (B, f, F; B, c, A; 
fb, R) 
Camp (B, f, F; B, c, A; 
Salm 
Typhimurium, 
Enteritidis (f) 
Ec (P, f, F; C, 
f, F; B, f, F; 
fb/fp/fc, R) 
na  x 
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*Food animal: P (pigs), C (cattle), S (sheep), B (broilers) 747 
Matrix (sample): c (caecum), f (faeces), cs (carcass swabs), fb (fresh broiler meat), fp (fresh pork meat), fc 748 
(fresh cattle meat), bl (blood), u (urine), cf (cerebrospinal fluid) 749 
Module in the meat chain: F (farm), A (abattoir), R (retail) 750 
†Zoonotic bacteria: Salm (Salmonella), Camp (Campylobacter), Yer (Yersinia), STEC (Shiga toxin producing E. 751 
coli) 752 
‡Non-zoonotic bacteria: Shi (Shigella) 753 
♯Commensals: Ec (Escherichia coli), En (Enterococcus faecium, Enterococcus faecalis) 754 
na: not applicable (the lack of data) 755 
 756 
fb, R) Camp  
Jejuni (f) 
STEC (f) 
 
En (P, c, A; 
fp, R) 
 
Sweden Salm (P, f, F; C, f, F; S, 
f, F) 
Camp (P, f, F; C, f, F; 
S, f, F) 
Salm (bl), 
Camp (bl) 
Ec (P, f/c, 
F/A,  C, f, A; 
B, c, A) 
En  (P, f/c, 
F/A,  C, f, A; 
B, c, A) 
na x  
Norway Salm (P, f/c, F/A; C, 
f/c, F/A; B, f/c, F/A) 
Camp (B, c, A)  
 
Salm 
Typhimurium, 
Enteritidis 
(bl, u, cf), 
Camp Jejuni  
(bl, u, cf), 
Yer 
enterocoilitca 
(bl, u, cf), 
‡Shi (bl, u, cf) 
Ec (B, f, F; 
fb, R) 
En ( B, f, F; 
fb, R ) 
na  x 
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4. Conclusion 757 
Over the last decade, the AMR associated with zoonotic foodborne pathogens is recognized 758 
as a major public health concern in Europe. Zoonotic foodborne bacteria are infectious agents 759 
which may be transferred from animals to humans via food consumption. Modern food-760 
animal production uses large amounts of antibiotics not only for therapeutic purposes but also 761 
to prevent disease and promote animal growth. As a result, large numbers of healthy animals 762 
are routinely or often exposed to antibiotics. Such intensive, on-farm production practice, can 763 
trigger a development of bacterial resistance towards antimicrobials. Food-producing animals 764 
(cattle, sheep, pigs and poultry) are of particular importance for emergence and transfer of 765 
AMR which may be transferred to humans. The use of antibiotics in one sector or 766 
environmental compartment or country may influence the spread of resistance in others. The 767 
special importance should be given to commensal microbiota (E. coli, enterococci). These 768 
bacteria can also acquire antimicrobial resistance as a response to selective pressures and may 769 
form a reservoir of resistance genes in environment, farm and food animals, with the potential 770 
for transferring resistance to pathogenic bacteria which, in turn, may cause infection in 771 
humans difficult to cure. Infections with foodborne pathogens (Salmonella, Campylobacter), 772 
resistant to antimicrobials, may result in serious treatment failures or necessitate the use of 773 
second-line antimicrobials for therapy.  774 
The review of available scientific and professional literature regarding contribution of the 775 
meat chain to development and transfer of AMR from meat animals to humans, revealed that 776 
in five selected countries – four EU MSs  (Denmark, France, Netherlands and Sweden) and 777 
one EEA country (Norway), healthy or diseased food-producing animals (cattle, pigs and 778 
poultry) and derived meats are regularly sampled - on farm, at abattoir and retail. The 779 
differences between these five countries regarding sampling schemes and susceptibility 780 
testing were evident (Table 4). A substantial difference was observed regarding food animal 781 
category, sample matrix (faeces, caecum, fresh meat) and module in the meat chain (farm, 782 
abattoir, retail) where sampling was conducted. In all five countries, detection and 783 
susceptibility testing for Salmonella and Campylobacter, as well as E. coli and enterococci 784 
was included in the national plan, although the selection of food animal category, matrix and 785 
module in the meat chain differed. The susceptibility testing for major zoonotic foodborne 786 
pathogens in humans (samples from blood, urine, cerebrospinal fluid) was carried out 787 
regularly for Salmonella typhimurium and Campylobacter jejuni - in Denmark, Netherlands, 788 
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Sweden and Norway; data from France were scarce and mostly related to individual studies 789 
regarding AMR profile of L. monocytogenes, Campylobacter and Salmonella. In Norway, 790 
other pathogens were also regularly included in the national AMR monitoring plan (Yersinia 791 
enterocolitica and Shigella, in humans). Data on susceptibility testing for commensals in 792 
humans were not available in neither of the five selected countries. The disk diffusion method 793 
is widely used in France and Sweden, while the dilution method is routinely used in 794 
Denmark, Netherlands and Norway. 795 
Integrated monitoring and surveillance of antimicrobial resistance in commensal and zoonotic 796 
foodborne bacteria from humans, animals and food is an essential source of information when 797 
formulating measures to improve food safety and protect consumers from exposure to 798 
resistant bacteria from foods. To harmonise the sampling and susceptibility testing and 799 
provide better consistency between EU MSs, the EFSA guidelines for the monitoring of 800 
antimicrobial resistance (e.g. target number of isolates per animal population - on farm, at 801 
abattoir and at retail; method of susceptibility testing; a panel of antimicrobials to be included 802 
and test ranges) should be applied. Such approach is also needed to improve the 803 
comparability of data generated among EU MSs.  804 
The effective risk mitigation strategies to tackle the antimicrobial resistance in the food 805 
(meat) chain context should be based on promotion of inter-sectoral cooperation at national 806 
and international level. Veterinary, agricultural and pharmaceutical authorities at the national 807 
level should give consideration to establishing a regulatory framework for authorizing and 808 
controlling veterinary medicines, including critically important antibiotics for veterinary 809 
medicine and human health. Integrating monitoring and surveillance in the environment-food 810 
animal-food (meat)-humans continuum is of utmost importance to tackle successfully the 811 
issue of antimicrobial resistance. The essential point is to reduce the need for antibiotics in 812 
food animal production systems by improving animal health through biosecurity measures, 813 
e.g. disease prevention (introduction of effective vaccines) and good hygiene and 814 
management practices – on farm and at abattoir. Future research needs should be based on 815 
knowledge gaps such as: securing comparable national data on the occurrence of antibiotic 816 
resistance in relevant bacteria from environment, food animals, food products and humans, 817 
including the use of various types of antibiotics in different categories of food animals; 818 
actively using surveillance data in epidemiological research and risk assessment, including 819 
the evaluation of interventions; improve the understanding of mechanisms of resistance 820 
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development and transfer; and development of new antibiotics and alternative approaches to 821 
antibiotic therapy. 822 
 823 
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